{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-281243","form_type":"8-K","ticker":"TCNNF","cik":"0001754195","company_name":"Trulieve Cannabis Corp.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.987958+00:00","generated_at":"2026-06-22T01:39:46.649132+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Trulieve Q3 revenue $301M (+34% YoY); net loss $115M with $93M impairments; adj. EBITDA $99M","bullets":["Revenue $301M (+34% YoY); 94% retail; GAAP gross margin 56%, gross profit $168M.","Net loss $115M includes $93M asset impairments from exiting CA dispensaries, redundant FL cultivation, and NV wholesale.","Adjusted net income $4M (excl. $26M transaction/integration charges & $93M impairments); adj. EBITDA $99M (33% margin).","Cash $114M; capex $38M; expects significant decline in supply chain investments in 2023.","Opened 11 new dispensaries in AZ, FL, WV; first Trulieve-branded store in Phoenix; began cultivation in Georgia."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-281243","json":"https://secwatch.observer/filing/0001193125-22-281243.json","markdown":"https://secwatch.observer/filing/0001193125-22-281243.md","text":"https://secwatch.observer/filing/0001193125-22-281243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1754195/000119312522281243/0001193125-22-281243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1754195/000119312522281243/d411970d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:39:46.649132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4982308f073a5b116319c19b9ce2201ba590a43d","claim":"Trulieve Cannabis Corp. reported financial results for three and nine months ended September 30, 2022.","evidence_excerpt":"On November 9, 2022, Trulieve Cannabis Corp. (the “Company”) announced via press release its results for the three and nine months ended September 30, 2022. A copy of the Company’s press release is hereby furnished to the Commission and incorporated herein by reference as Exhibit 99.1.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1754195/000119312522281243/0001193125-22-281243-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}